These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7888102)

  • 1. Proteoglycans and the acute-phase response in Alzheimer's disease brain.
    Leveugle B; Fillit H
    Mol Neurobiol; 1994; 9(1-3):25-32. PubMed ID: 7888102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
    Buée L; Ding W; Delacourte A; Fillit H
    Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
    Su JH; Cummings BJ; Cotman CW
    Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
    Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
    Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
    Benditt EP
    Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE].
    Szarka A
    Ideggyogy Sz; 2015 Jul; 68(7-8):222-8. PubMed ID: 26380416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
    Perlmutter LS; Chui HC; Saperia D; Athanikar J
    Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
    Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
    Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis.
    Young ID; Willmer JP; Kisilevsky R
    Acta Neuropathol; 1989; 78(2):202-9. PubMed ID: 2473595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].
    Ikeda S
    Yakubutsu Seishin Kodo; 1992 Jun; 12(3):141-9. PubMed ID: 1414034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease.
    Snow AD; Lara S; Nochlin D; Wight TN
    Acta Neuropathol; 1989; 78(2):113-23. PubMed ID: 2473592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.
    Small DH; Williamson T; Reed G; Clarris H; Beyreuther K; Masters CL; Nurcombe V
    Ann N Y Acad Sci; 1996 Jan; 777():316-21. PubMed ID: 8624106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.